$OBMP CRO news... “Experts in oncology and th
Post# of 110
(Total Views: 359)
Posted On: 03/08/2018 10:08:39 AM
$OBMP CRO news...
“Experts in oncology and the clinical process, Theradex was invaluable to us in the initial trial of ProscaVax and we’re certain that their experience and guidance will again be of utmost importance in the planned mid-stage studies,” commented Dr. Jonathan Head, Chief Executive Officer at OncBioMune. “What we are trying to achieve by addressing prostate cancer at the earliest stage and in the most advanced stage is critically important to improving patient care in a cancer with very limited options across the disease spectrum. We look forward to working with Theradex again and to getting these studies underway.”
https://finance.yahoo.com/news/oncbiomune-sel...00471.html
“Experts in oncology and the clinical process, Theradex was invaluable to us in the initial trial of ProscaVax and we’re certain that their experience and guidance will again be of utmost importance in the planned mid-stage studies,” commented Dr. Jonathan Head, Chief Executive Officer at OncBioMune. “What we are trying to achieve by addressing prostate cancer at the earliest stage and in the most advanced stage is critically important to improving patient care in a cancer with very limited options across the disease spectrum. We look forward to working with Theradex again and to getting these studies underway.”
https://finance.yahoo.com/news/oncbiomune-sel...00471.html
(0)
(0)Theratechnologies Inc. (THER) Stock Research Links
Scroll down for more posts ▼